Replies to post #13376 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[MWM]

I totally missed earnings because i took this garbage off my watchlist!

Just like I said, this Antbloc crap can't make money even when you pay people to buy it...

Losing money at a record Pace! It's such a Joke!


Star Scientific Q2 Revenues Grow, Net Loss Deepens
By Eric Volkman

STSI Star Scienti

Star Scientific (NASDAQ: STSI ) is reporting mixed results for its Q2. The quarter saw the company post net sales of $2.5 million, a 74% improvement over the $1.4 million it reaped in the same period the previous year. Net loss, on the other hand, deepened to almost $8.7 million ($0.05 per diluted share) from Q2 2012's red figure of $8.0 million ($0.06).

For the first six months of 2013, the company's top line came in at just over $5 million, nearly double the $2.5 million of the year-ago period. Net loss was $16.9 million ($0.10 per diluted share), against a shortfall of $13.2 million ($0.09) in the first six months of 2012.

Star Scientific attributed the pronounced growth in top line exclusively to sales of Anatabloc, an anti-inflammatory medication developed by its fully owned subsidiary Rock Creek Pharmaceuticals.

[Teedlum]

Hey leif, wait until Friday afternoon and see if they take this down below $2 to the $2 options expire out of the money. That will be a great buying opportunity, imo. best wishes.